Azithromycin for mild-to-moderate COVID-19 - Authors' reply

Podobne zapisy

• Azithromycin for mild-to-moderate COVID-19: author's reply
  od: Hinks, TSC, i wsp.
  Wydane: (2021)
• Azithromycin in viral infections
  od: Oliver, ME, i wsp.
  Wydane: (2020)
• Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
  od: Elisa Baranski Lamback, i wsp.
  Wydane: (2021-03-01)
• Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
  od: Hinks, TSC, i wsp.
  Wydane: (2021)
• Author’s Reply—Is it really COVID-19?
  od: David Chang, MD, i wsp.
  Wydane: (2020-07-01)